The Spleen Tyrosine Kinase (Syk) in Human Disease, Implications for Design of Tyrosine Kinase Inhibitor Based Therapy

By  

Current Pharmaceutical Design, Vol. 10, Iss. 15, 2004-06 ,pp. : 1739-1744

Bentham Science Publishers

Access to resources Recommend Favorite

Genistein, an inhibitor of tyrosine kinase, prevents the antiarrhythmic effects of preconditioning

By Fatehi-Hassanabad Z.   Parratt J.R.  

European Journal of Pharmacology, Vol. 338, Iss. 1, 1997-10 ,pp. : 67-70

Elsevier

Access to resources Recommend Favorite

Vatalanib: the clinical development of a tyrosine kinase inhibitor of angiogenesis in solid tumours

By Scott Edwina N   Meinhardt Gerold   Jacques Christian   Laurent Dirk   Thomas Anne L  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 3, 2007-03 ,pp. : 367-379

Informa Healthcare

Access to resources Recommend Favorite

PCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignancies

By Winer Eric S   Ingham Randall R   Castillo Jorge J  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 3, 2012-03 ,pp. : 355-361

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Chronic Myeloid Leukemia Elderly Patients in the Tyrosine Kinase Inhibitor Era

By  

Current Cancer Drug Targets, Vol. 13, Iss. 7, 2013-09 ,pp. : 755-767

Bentham Science Publishers

Access to resources Recommend Favorite